| Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine LR Baden, HM El Sahly, B Essink, K Kotloff, S Frey, R Novak, D Diemert, ... New England journal of medicine 384 (5), 403-416, 2021 | 10204 | 2021 |
| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1797 | 2021 |
| The Beta-Glucan Receptor Dectin-1 Recognizes Specific Morphologies of Aspergillus fumigatus C Steele, RR Rapaka, A Metz, SM Pop, DL Williams, S Gordon, JK Kolls, ... PLoS pathogens 1 (4), e42, 2005 | 620 | 2005 |
| Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase HM El Sahly, LR Baden, B Essink, S Doblecki-Lewis, JM Martin, ... New England Journal of Medicine 385 (19), 1774-1785, 2021 | 534 | 2021 |
| Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico LM Dunkle, KL Kotloff, CL Gay, G Áñez, JM Adelglass, ... New England Journal of Medicine 386 (6), 531-543, 2022 | 366 | 2022 |
| Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ... The lancet respiratory medicine 9 (12), 1365-1376, 2021 | 146 | 2021 |
| Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina RR Rapaka, DM Ricks, JF Alcorn, K Chen, SA Khader, M Zheng, S Plevy, ... Journal of Experimental Medicine 207 (13), 2907-2919, 2010 | 145 | 2010 |
| CD4+ T cell–independent DNA vaccination against opportunistic infections M Zheng, AJ Ramsay, MB Robichaux, KA Norris, C Kliment, C Crowe, ... The Journal of clinical investigation 115 (12), 3536-3544, 2005 | 100 | 2005 |
| Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial CR Wolfe, KM Tomashek, TF Patterson, CA Gomez, VC Marconi, MK Jain, ... The lancet respiratory medicine 10 (9), 888-899, 2022 | 89 | 2022 |
| Are some COVID-19 vaccines better than others? Interpreting and comparing estimates of efficacy in vaccine trials RR Rapaka, EA Hammershaimb, KM Neuzil Clinical Infectious Diseases 74 (2), 352-358, 2022 | 56 | 2022 |
| Immune reconstitution inflammatory syndrome associated with pulmonary pathogens R Gopal, RR Rapaka, JK Kolls European Respiratory Review 26 (143), 2017 | 55 | 2017 |
| Diagnostics for tuberculosis: global demand and market potential Foundation for Innovative New Diagnostics, ... World Health Organization, 2006 | 54 | 2006 |
| Enhanced defense against Pneumocystis carinii mediated by a novel dectin-1 receptor Fc fusion protein RR Rapaka, ES Goetzman, M Zheng, J Vockley, L McKinley, JK Kolls, ... The Journal of Immunology 178 (6), 3702-3712, 2007 | 51 | 2007 |
| Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions RR Rapaka, JK Kolls Medical mycology 47 (Supplement_1), S331-S337, 2009 | 47 | 2009 |
| Dectin-1 Fc Targeting of Aspergillus fumigatus Beta-Glucans Augments Innate Defense against Invasive Pulmonary Aspergillosis PE Mattila, AE Metz, RR Rapaka, LD Bauer, C Steele Antimicrobial agents and chemotherapy 52 (3), 1171-1172, 2008 | 47 | 2008 |
| Using adjuvants to drive T cell responses for next-generation infectious disease vaccines RR Rapaka, AS Cross, MA McArthur Vaccines 9 (8), 820, 2021 | 22 | 2021 |
| Bartlett's Medical Management of HIV Infection JG Bartlett, RR Redfield Jr, PA Pham Oxford University Press, 2019 | 11 | 2019 |
| Remdesivir for the prevention of invasive mechanical ventilation or death in coronavirus disease 2019 (COVID-19): a post hoc analysis of the Adaptive COVID-19 Treatment Trial-1 … CI Paules, SK Gallagher, RR Rapaka, RT Davey, SB Doernberg, ... Clinical Infectious Diseases 74 (7), 1260-1264, 2022 | 9 | 2022 |
| Bigger foot: Kaposi's sarcoma RR Rapaka, M Fischer, TE Finucane, A Mwakingwe The American Journal of Medicine 128 (9), 959-962, 2015 | 7 | 2015 |
| Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19-A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data CI Paules, SK Gallagher, RR Rapaka, RT Davey, SB Doernberg, ... Clinical Infectious Diseases 74 (7), ciab695-, 2022 | 5 | 2022 |
